Cornerstone Capital Management Holdings LLC. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 429,721 shares of the healthcare conglomerate’s stock after selling 67,177 shares during the period. UnitedHealth Group accounts for about 0.5% of Cornerstone Capital Management Holdings LLC.’s portfolio, making the stock its 26th biggest holding. Cornerstone Capital Management Holdings LLC.’s holdings in UnitedHealth Group were worth $70,477,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jackson Grant Investment Advisers Inc. lifted its position in shares of UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares in the last quarter. Harwood Advisory Group LLC lifted its position in shares of UnitedHealth Group by 0.8% in the first quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 15 shares in the last quarter. Budros Ruhlin & Roe Inc. lifted its position in shares of UnitedHealth Group by 0.8% in the first quarter. Budros Ruhlin & Roe Inc. now owns 1,832 shares of the healthcare conglomerate’s stock worth $301,000 after buying an additional 15 shares in the last quarter. Finally, Hanson McClain Inc. lifted its position in shares of UnitedHealth Group by 1.7% in the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after buying an additional 15 shares in the last quarter. 86.21% of the stock is owned by hedge funds and other institutional investors.

In related news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the transaction, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 25,000 shares of company stock worth $4,758,750 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.

Shares of UnitedHealth Group Incorporated (UNH) traded up 0.43% during midday trading on Monday, hitting $199.75. The stock had a trading volume of 2,242,195 shares. UnitedHealth Group Incorporated has a 52-week low of $132.39 and a 52-week high of $199.99. The firm has a market cap of $193.13 billion, a price-to-earnings ratio of 24.00 and a beta of 0.63. The firm’s 50 day moving average price is $192.88 and its 200 day moving average price is $178.33.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the prior year, the company earned $1.96 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date of this dividend is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/04/unitedhealth-group-incorporated-unh-stake-decreased-by-cornerstone-capital-management-holdings-llc.html.

UNH has been the topic of a number of research analyst reports. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price on the stock in a research report on Monday, May 15th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Jefferies Group LLC reiterated a “buy” rating and issued a $192.00 target price on shares of UnitedHealth Group in a research report on Friday, May 19th. Finally, Morgan Stanley initiated coverage on UnitedHealth Group in a research report on Tuesday, June 6th. They issued an “overweight” rating and a $202.00 target price on the stock. One investment analyst has rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $203.41.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.